Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22,093 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sustained complete response to first-line immunochemotherapy for highly aggressive TP53/MDM2-mutated upper tract urothelial carcinoma with ERBB2 mutations, luminal immune-infiltrated contexture, and non-mesenchymal state: a case report and literature review.
Xu T, Guo H, Xie J, He Y, Che J, Peng B, Yang B, Yao X. Xu T, et al. Among authors: yang b. Front Oncol. 2023 Jun 23;13:1119343. doi: 10.3389/fonc.2023.1119343. eCollection 2023. Front Oncol. 2023. PMID: 37427135 Free PMC article.
Re: Michael S. Hofman, Louise Emmett, Shahneen Sandhu, et al. Overall Survival with [177Lu]Lu-PSMA-617 Versus Cabazitaxel in Metastatic Castration-resistant Prostate Cancer (TheraP): Secondary Outcomes of a Randomised, Open-label, Phase 2 Trial. Lancet Oncol 2024;25:99-107.
Xu J, Ding L, Yang B. Xu J, et al. Among authors: yang b. Eur Urol Oncol. 2024 Oct;7(5):1150-1151. doi: 10.1016/j.euo.2024.02.001. Epub 2024 Feb 19. Eur Urol Oncol. 2024. PMID: 38378399 No abstract available.
BRD4 inhibition impairs DNA mismatch repair, induces mismatch repair mutation signatures and creates therapeutic vulnerability to immune checkpoint blockade in MMR-proficient tumors.
Fu Y, Yang B, Cui Y, Hu X, Li X, Lu F, Qin T, Zhang L, Hu Z, Guo E, Fan J, Xiao R, Li W, Qin X, Hu D, Peng W, Liu J, Wang B, Mills GB, Chen G, Sun C. Fu Y, et al. Among authors: yang b. J Immunother Cancer. 2023 Apr;11(4):e006070. doi: 10.1136/jitc-2022-006070. J Immunother Cancer. 2023. PMID: 37072347 Free PMC article.
22,093 results
You have reached the last available page of results. Please see the User Guide for more information.